Procaps Group S A Receivables Turnover Ratio (PROCF), from the fourth quarter 2023 to the fourth quarter 2022 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Procaps Group S a   (PROCF)
 

Procaps Group S A Accounts Receivables Turnover Ratio from the fourth quarter 2023 to the fourth quarter 2022

Quarterly Results, Trends, Rankings, Statistics


Procaps Group S A 's ability to collect accounts receivable sequentially worsen to 5.95, indicating more challenging environment then in the third quarter 2023, but still, it is a far cry from any concerns. Procaps Group S A 's Accounts Receivable average collection period in the Dec 31 2023 quarter, has increased to 61 days, from 48 days, in the 0 quarter.

If we take a look into Healthcare sector 103 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2023 from to 1174.

What is Receivable Turnover Ratio?
What is Procaps Group S A Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PROCF Receivables Turnover Ratio (Dec 31 2023)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2022)
IV. Quarter
Y / Y Receivable Change - 24.61 % - - -
Y / Y Revenue Change 3.37 % - -2.1 % - -
Receivable Turnover Ratio (TTM) 5.95 7.68 8.51 8.55 19.56
PROCF's Total Ranking # 1174 # # # #
Accounts Receivable average collection period days 61 48 43 43 19
Seq. Receivable Change -33.58 % - - - -
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 25
Healthcare Sector # 104
Overall Market # 1174

Receivable Turnover Ratio Statistics
High Average Low
0.9 0.9 0.9
(Dec 31 2023)  





PROCF Company Profile • Back to PROCF Efficiency Comparisons • Compare PROCF Receivables Turnover Ratio to its Competitors

Financial Statements
Procaps Group S A 's Accounts Receivable $ 88 Millions Visit PROCF's Balance sheet
Procaps Group S A 's Sales TTM $ 534 Millions Visit PROCF's Income Statement
Sources of PROCF's Revenues Visit PROCF's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PROCF's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PROCF's Growth Rates PROCF's Roa PROCF's Inventory Turnover Ratio PROCF's Dividend Comparisons
PROCF's Profitability Ratios PROCF's Roi PROCF's Asset Turnover Ratio PROCF's Dividend Growth
PROCF's Valuation Ratios PROCF's Roe PROCF's Financial Strength Ratios PROCF's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Wave Life Sciences Ltd   16.14 $ 113.305  Millions$ 7.022  Millions
Recursion Pharmaceuticals Inc   15.69 $ 44.575  Millions$ 2.842  Millions
Trisalus Life Sciences Inc   15.44 $ 25.502  Millions$ 1.652  Millions
Talkspace Inc   15.31 $ 149.380  Millions$ 9.757  Millions
Xortx Therapeutics inc   15.15 $ 0.919  Millions$ 0.061  Millions
Milestone Scientific Inc   15.03 $ 9.793  Millions$ 0.651  Millions
Neuroone Medical Technologies Corp  14.87 $ 2.816  Millions$ 0.189  Millions
Chemed Corporation  14.52 $ 2,264.417  Millions$ 155.918  Millions
Icu Medical Inc  14.46 $ 2,259.126  Millions$ 156.262  Millions
Lftd Partners Inc   14.38 $ 51.611  Millions$ 3.588  Millions
Centogene N v   14.16 $ 54.319  Millions$ 3.836  Millions
Newgenivf Group Limited  14.12 $ 5.136  Millions$ 0.364  Millions
Patterson Companies Inc   14.11 $ 6,565.239  Millions$ 465.318  Millions
Corcept Therapeutics Inc  13.70 $ 482.375  Millions$ 35.215  Millions
Theralink Technologies Inc   13.67 $ 0.511  Millions$ 0.037  Millions
Precipio inc   13.43 $ 15.197  Millions$ 1.132  Millions
Protalix Biotherapeutics inc   13.39 $ 65.494  Millions$ 4.890  Millions
Lifeloc Technologies Inc   13.20 $ 9.330  Millions$ 0.707  Millions
Exact Sciences Corporation  13.11 $ 2,507.149  Millions$ 191.178  Millions
Traws Pharma inc   12.91 $ 0.226  Millions$ 0.018  Millions
Fate Therapeutics Inc   12.90 $ 63.533  Millions$ 4.924  Millions
Ideaya Biosciences Inc   12.73 $ 23.385  Millions$ 1.837  Millions
Amylyx Pharmaceuticals Inc   12.65 $ 380.786  Millions$ 30.108  Millions
Valion Bio Inc   12.54 $ 1.176  Millions$ 0.094  Millions
Utah Medical Products Inc  12.39 $ 50.658  Millions$ 4.088  Millions
Teladoc Health Inc   12.18 $ 2,602.415  Millions$ 213.613  Millions
International Stem Cell Corporation  12.13 $ 7.789  Millions$ 0.642  Millions
Caribou Biosciences Inc   12.12 $ 34.477  Millions$ 2.844  Millions
Zomedica Corp   12.01 $ 24.318  Millions$ 2.025  Millions
Avita Medical Inc   11.98 $ 50.143  Millions$ 4.185  Millions

Date modified: 2026-09-02T18:50:17+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.